investigating the effects of the chemical composition on ... · hydrolytic and corrosion resistance...
TRANSCRIPT
10.5731/pdajpst.2019.010066Access the most recent version at doi: 185-20074, 2020 PDA J Pharm Sci and Tech
Serena Panighello and Odra Pinato Glass Corrosion: A Case Study for Type I VialsInvestigating the Effects of the Chemical Composition on
on June 14, 2020Downloaded from on June 14, 2020Downloaded from
RESEARCH
Investigating the Effects of the Chemical Composition onGlass Corrosion: A Case Study for Type I Vials
SERENA PANIGHELLO* and ODRA PINATO
SG Lab Analytics, Nuova Ompi, Piombino Dese, Italy © PDA, Inc. 2020
ABSTRACT: Glass is the favorite material for parenteral packaging because of its physico-chemical properties. Type I
borosilicate glass is worldwide use at this scope, but it may have some issues related to breakage, corrosion and delami-
nation that might compromise the drug quality, safety and efficacy. These issues can be mitigated and avoided starting
from the appropriate selection of the most suitable raw material at the early stage of the glass container design. In this
study, Type I borosilicate glass vials manufactured using two glass tubes having different chemical compositions, were
studied and compared in terms of their resistance to corrosion. Testing design was applied with the aim to select the
best practice approach comparing different storage simulation conditions: ageing treatment through autoclaving and
stability testing (real-time and accelerated). Clear differences were found between the different glass types in terms of
hydrolytic and corrosion resistance that highlighted the relation between chemical composition and glass chemical du-
rability. Non-negligible differences were also observed using different storage conditions.
KEYWORDS: Glass primary packaging, Surface chemistry, Glass corrosion, Glass delamination, Stability studies,
Hydrolytic resistance.
Introduction
Glass is one of the oldest human-made materials that
since ancient Egyptian times has been considered the
ideal choice to store medications or other precious
liquids. Nowadays, glass is still widely used as the pri-
mary packaging for pharmaceuticals thanks to its unique
combination of physicochemical proprieties, such as
transparency, strength, and chemical durability (1, 2).
The expression chemical durability is conventionally
used to denote the resistance of a glass toward attack by
aqueous solutions or atmospheric agents (3, 4), but no
explicit measure for the chemical durability is defined
(2, 3, 5). However, different tests such as those for the
hydrolytic resistance [ISO 720, ISO 4802-1 and 4802-2,
United States Pharmacopeia (USP) <660>, and Euro-
pean Pharmacopoeia (Ph Eur) 3.2.1] are usually carried
out to provide information regarding the intrinsic dura-
bility of a specific glass only in contact with water. To
further increase the knowledge regarding key contribu-
tion factors to glass corrosion/delamination, USP
<1660> provides advice on the evaluation of the inner
surface durability for glass containers in direct contact
with different pharmaceutical products.
According to the current Ph Eur and USP, glass tubes
for pharmaceutical use are classified into Type I (boro-
silicate) and Type III (soda lime) glasses. The chemical
composition of these glasses is well-known and defined
in various standards (6).
Type I borosilicate glass containers are the most suita-
ble for use in contact with parenteral preparation
according to the Ph Eur and USP. Type I borosilicate
definition comprises different chemical compositions
that can have an impact on the glass performances
postforming process. Thus, are Type I glasses the same
in terms of glass–drug interaction?
How Does the Chemical Composition of Glass Relate to
the Degradation Process?
The interaction of borosilicate glass with aqueous sol-
utions occurs according to a complex reaction that is
directly dependent on its chemical composition.
* Corresponding Author: SG Lab Analytics, Nuova
Ompi, via Molinella 17, 35017 Piombino Dese (PD),
Italy; e-mail: [email protected]
doi: 10.5731/pdajpst.2019.010066
Vol. 74, No. 2, March--April 2020 185
on June 14, 2020Downloaded from
In general, the degradation model is based on the generation
of a chemically and structurally distinct superficial altered
zone, which is often divided into a diffusion zone (ion-
exchange/leaching) and a gel zone (3, 7). The former is
related to the glass being attacked by acids or acidic aque-
ous solutions and can be considered a pure ion-exchange
between alkaline ions of the glass and H+ (or H3O+) ions of
the acidic agent (8). The acid attack on the glass, linked to
the diffusion mechanism, decreases as a function of the
square root of the contacting time (t½); consequently, the
chemical durability of glass improves with time. Simultane-
ously to the attack reactions that take place, water molecules
are incorporated into the surface, forming a thin gel layer.
This gel layer forms a superficial interface that delays or
prevents further chemical attack inside the glass body.
The outstanding chemical durability of some borosili-
cate glasses is owing to their particular structure. They
have a silica matrix in which a second phase of sodium
borosilicate is dispersed. The reactivity toward acidic
solutions is similar to that of the silica lattice because
the borosilicate phase is practically impenetrable
owing to the high-pressure required to force liquid
water within very narrow capillary channels (5, 8, 9).
The attack from alkaline solutions is determined by another
mechanism. In this case, the OH� ion plays a determining
role; it reacts with the lattice breaking the oxygen bridges.
The glass alkaline attack is not a selective first-order reac-
tion (the rate of reaction is proportional to the OH� ions
concentration). The amount of glass brought into solution
during the corrosion process increases linearly over time.
The prevalence of one of these mechanisms is also a
function of the glass chemical composition and the
environmental conditions (e.g., temperature and rela-
tive humidity).
The hydrated or gel layer generates superficial stress
tensions between the corroded layer and the pristine
glass. When the hydrated layer is thick enough, glass
flakes or lamellae can be released from the surface
(10–15). This form of glass corrosion, generally
referred to as delamination in pharmaceutical glass
literature, results in the appearance of visible glass
particles, generally known as flakes (lamellae).
Corrosion Propensity of Pharmaceutical Glass
The corrosion propensity of pharmaceutical glass is
affected by the combination of several factors, starting
from the manufacturing process to the storage of the
final product. These factors include the type of glass
used (e.g., with a different coefficient of thermal
expansion: exp. 33 and exp. 51, different B2O3 content,
and so forth) and surface treatments (e.g., ammonium
sulfate, siliconization, or special coatings), but also for-
mulation and pH of the filling media. In addition, all
the external stresses exerted during the manufacturing
processes (washing, depyrogenation, sterilization) and
the storage conditions (time, temperature, humidity)
have a significant impact on the degradation phenom-
enon (16–20).
In the glass primary packaging, autoclave (AC) stress
treatment is defined and used to simulate the aging pro-
cess and as a stress treatment for the study of glass
chemical durability, as prescribed by Ph Eur 3.2.1 and
USP <660>.
For pharma application, autoclaving is routinely used
as standard terminal sterilization method; on the con-
trary, the glass world exploits its straightforward and
low time-consuming features for both extraction and
aging procedures. On the other hand, the pharmaceu-
tical vocabulary does not refer to the term “aging”
but rather to “stability” using storage facilities (e.g.,
climatic chambers). ICH Q1A guidelines clearly
state that stability testing has the specific purpose to
provide evidence on how the quality of a drug sub-
stance or product varies with time under the influ-
ence of a variety of environmental factors such as
temperature, humidity, and light, and to establish a
retest period for the drug substance or a shelf life for
the drug product and recommended storage condi-
tions (21).
Up to now, the commitment of the glass packaging
world was and is “to be in compliance” with the phar-
macopeias’ requirements in terms of glass durability.
It should be noted that, to meet the new pharmaceuti-
cal needs and demands, a harmonization of terminolo-
gies (e.g., the mixing up of “aging” and “stability”
terms) and an improvement in testing approaches are
desirable.
Based on these premises, all the predictive studies
regarding the interaction between the primary packag-
ing and the drug product should be driven by the stabil-
ity assessment with the common intent to preserve the
integrity of the drug and, thus, its quality, safety, and
efficacy.
186 PDA Journal of Pharmaceutical Science and Technology
on June 14, 2020Downloaded from
In the present case study, 2R glass vials manufactured
using two glass tubes having different chemical compo-
sition and different hydrolytic resistance are compared
in terms of their resistance to corrosion after filling them
with a real drug formulation (nonbuffered ionic strength
solution, which is one of the placebo solutions of drugs
currently on the market; e.g., vaccines) and real drug
quantity (0.7mL is representative of real drug formula-
tion). As well, high surface area to volume (SA/V) ratio
provides accelerated glass surface reactions in the rele-
vant vial lower area.
Beyond the role of the raw material chemical composi-
tion, aging and stability approaches will be also compared
in terms of glass primary packaging, physicochemical
performances, and suitability, to obtain preliminary infor-
mation as a guideline for further wider studies about the
chemical resistance of pharmaceutical glasses with differ-
ent filling media.
Material and Methods
Instrumentation
Visual Inspection: For the visual assessment of the so-
lution quality, after each stability time-point, a suitable
apparatus for visible particles was used according to Ph
Eur 2.9.20 Particulate contamination: Visible Particles.
The outer surface of every container was accurately
cleaned; subsequently, every vial was gently swirled up,
avoiding the formation of air bubbles and observed for
about 5 s in front of a white panel under illumination by
a cold white light. The procedure was repeated in front
of a black panel.
Confocal Differential Interference Contrast Micro-
scopy: Differential interference contract (DIC) micros-
copy is normally used in the biological field and consti-
tutes an excellent method for generating contrast by
converting specimen optical path gradients into ampli-
tude differences that can be visualized by the human
eye.
The use of this specific tool for the analysis of glass
vials without any glass sample cutting is well explained
by Wen et al. (22). Compared with scanning electron
microscopy (SEM) analysis, DIC microscopy can
examine the entire vial sidewall by translation and rota-
tion of the sample vial on the stage.
The analysis of the inner surface of the vials was per-
formed by a Zeiss Axio imager M2m microscope
equipped with a Circular Polarized Light-Differential
Interference Contrast (C-DIC) slider 6� 20 for EC
EPN 5–20�, using a 10� long working distance
objective.
Once the glass vial was laid horizontally on the sample
holder and the area to investigate was identified, a
micrograph was taken and recorded with a digital cam-
era (Axio camera). Three main glass surface areas were
analyzed, as reported in Figure 1a. In Type I pharma-
ceutical glass vials, the shoulder and the wall-near-bot-
tom are critical areas for corrosion because high-
temperature flames are applied during the conversion
process.
Inductively Coupled Plasma Analysis: Inductively
coupled plasma optical emission spectroscopy (ICP-
OES) was performed on the extracted solution of each
vial to quantitatively determine the concentration of
the leached-out glass elements. The ICP-OES instru-
ment is a Thermo Scientific iCAP7400. To estimate
the content of Al, B, Ca, and Si in the extracted solu-
tion, four levels of calibration curves using the internal
standard method for each analyte were determined.
Limit of quantification (LoQ) values were 0.05mg/L
for Al, B, and Ca and 0.2 mg/L for Si.
Figure 1
Three-dimensional image reconstruction of the vial
with the three main analyzed areas. (a) for light
microscopy (DIC); (b) for SEM.
Vol. 74, No. 2, March--April 2020 187
on June 14, 2020Downloaded from
The chemicals used are reported below:
� H2O Milli-Q, produced by MILLIPORE-IQ 7000
system, Merck;
� Concentrated nitric acid, Sigma-Aldrich;
� Y standard solution 1000mg/L, Inorganic Ventures;
� Al standard solution 1000mg/L, Inorganic Ventures;
� B standard solution 1000mg/L, Inorganic Ventures;
� Si standard solution 1000mg/L, Inorganic Ventures;
� Ca standard solution 1000mg/L, Inorganic Ventures.
The reference solutions used to calculate the calibra-
tion curve were prepared by dilution of certified ready-
to-use standard stock solution at 1000mg/L for each
analyte and for the internal standard (yttrium; final con-
centration, 1.0 mg/L).
The correlation coefficient (r ≥ 0.99) and the accuracyon two quality check solutions after calibration and ev-ery 10 samples for each analyte were calculated to testthe system reliability.
The elemental concentration results were then pre-
sented as element oxides through the stoichiometric ra-
tio between each element and its oxide.
SEM: SEM analysis was performed using a ZEISS
Sigma field emission scanning electron microscope with
1.5 nm of maximum resolution. SEM technique is based
on a focused electron beam used as a probe to inspect
the surfaces of almost any kind of solid material, and
different integrated detectors can be used to collect the
generated particles to evaluate sample morphology.
The morphological investigation of the inner vial sur-
face was performed over the three areas described in
Figure 1b.
Samples
2R glass vials provided by Nuova Ompi Srl were
selected for this study. Because the forming process is
an essential step in the generation of glass pharma con-
tainers, a proprietary process called low delamination
propensity (LDP) was chosen to investigate the glass du-
rability based on the composition of the selected raw
materials. This process is based on the smoothing of dif-
ferent aspects related to the conversion process, such as
speed, burners’ flame temperature, and annealing stage,
that decrease the manufacturing process impact.
The propensity of a vial to delaminate is tested with an
analytical protocol based on a stress treatment [Auto-
clave cycle (AC) cycle of 1 h at 121 ˚C] in contact with
a high ionic strength solution, pH 8.
The evaluation criteria are selected through a compari-
son study between standard and LDP process vials, and
they are based on the parameters normally used to eval-
uate delamination phenomenon: morphological analy-
sis and glass extracted elements (i.e., Si, Al, and B).
These specific vials that underwent the abovemen-
tioned procedure were used with the aim to limit all the
conversion process factors that can affect the corrosion
propensity of pharmaceutical glass and, thus, to better
study the impact of the chemical composition.
The vials were produced with two different glass tubes
named A and B. Glass chemical composition of the
clear glass vials is reported in Table I.
The main differences on the chemical composition are
related to the fluxes, so-called because co-adjuvants of
the melting process, and to the stabilizer agents such
as calcium, barium, aluminum, and boron oxides.
Glass B shows a slightly higher amount of fluxes with
a combination of Na2O and K2O and a higher content
of different stabilizer agents—B2O3 (10 wt %), Al2O3
(7.5 wt %), and CaO + BaO (2 wt %)—compared with
Glass A.
TABLE I
Glass Chemical Composition Expressed as Elemental Oxides (wt %) from Supplier A and Supplier B
Chemical Composition (wt %) SiO2 B2O3 Al2O3 Na2O K2O CaO+ BaO Other Elements
Glass A 74 9.5 6.5 7.8 <0.1 1.5 0.7
Glass B 72 10 7.5 6.0 1.9 2.0 0.6
188 PDA Journal of Pharmaceutical Science and Technology
on June 14, 2020Downloaded from
Experimental Design
A total of 150 samples per category (2R vials with A
and B chemical composition) were filled with an ionic
placebo solution of 0.3% NaCl formulation, pH around
6.0. The filling volume was 0.7mL; that is about
17.5% of a 2R vial brimful volume.
Samples were submitted to real-time and accelerated
stability testing conditions and to AC and then ana-
lyzed at different time-points, as reported in Table II.
AC stress treatment is aimed to simulate an aging
effect on a filled glass container. Lyle represented the
effects of time and temperature on the chemical attack
of glass by an equation similar to the Arrhenius one:
aLogN ¼ Logh� bT þ c, where N = attack, h = time, T =
absolute temperature, and a, b, and c are experimen-
tally determined constants. According to the overre-
ported Lyle equation (23), an AC cycle of 60 min at
121 ˚C simulates a storage time of 2 y at room-tempera-
ture (23, 24). The accelerated conditions were selected
in accordance with the Arrhenius equation.
Per each time-point on both empty and filled vials,
morphological analysis was carried out by light micros-
copy with DIC tool and SEM. ICP-OES analysis of the
extracted solutions was performed before and after sta-
bility time-points and AC stress treatment.
Results and Discussion
Visual Inspection
The method to check for the presence of visible partic-
ulate contamination is well explained on the USP
<790>/Ph Eur 2.9.20. It consists of a simple procedure
that gives guidelines for the visual assessment of the
parenteral solution’s quality.
The presence of particles was tested before and after
stability and AC stress treatment for A and B glasses.
No particle was observed by visual inspection in all the
categories.
However, it should be stated that there are limitations
to visual inspection, such as wrong discrimination
between air bubbles and particles or the necessity to
use other techniques to characterize the particles, such
as light obscuration or microflow imaging.
Morphological Results
DIC images (DIC microscopy images of the wall-near-
bottom area are reported as supplementary material)
showed that the inner surface of Glass A vials dis-
played inhomogeneities (white dots) on the shoulder
and wall-near-bottom areas even before filling and
stress treatments. The middle body surface was homo-
geneous and smooth.
There is an increase on the density and distribution of
these inhomogeneities from T0 to time-point AT36 and
AC. Instead, samples of Glass B showed fewer inho-
mogeneities on the wall-near-bottom surface at T0
compared with Glass A, but a higher degree of imper-
fections after stability and AC stress treatment.
The preexisting inhomogeneities are attributed to alkali
borate-rich regions generated during the parting and
smoothing of the vial bottom forming process. It is
worth noting that with DIC microscopy observation, it
TABLE II
Storage Conditions Descriptiona
ID Time Point Description Conditions Simulated Time (mo)
T0 Freshly filled — 0
RT5 5mo 25 ˚C6 2 ˚C; 40% HR 5
RT12 12mo 25 ˚C6 2 ˚C; 40% HR 12
RT24 24mo 25 ˚C6 2 ˚C; 40% HR 24
AT12 5weeks 60 ˚C6 2 ˚C; 40% HR 12
AT24 10weeks 60 ˚C6 2 ˚C; 40% HR 24
AT36 15weeks 60 ˚C6 2 ˚C; 40% HR 36
AC Autoclave stress treatment Cycle: 60min at 121 ˚C 24aRT, real-time; AT, accelerated time; AC, autoclave cycle.
Vol. 74, No. 2, March--April 2020 189
on June 14, 2020Downloaded from
is difficult to discriminate between bulges (alkali
borate-rich regions) and pits. The latter are typical of
“pitting corrosion” that can occur when corrosion has a
preferential starting point either on or just below the
surface (12, 25). An interesting point is that the form-
ing of craters and pits occurs generally after water or
acid attack to the enriched alkali and boron areas of the
surface (26, 27).
SEM investigation was performed to characterize, at
higher magnification, the morphology of the inner sur-
face of the vial samples at different time-points, focus-
ing the analysis on the inspected regions, as shown in
Figure 2 and 3.
Morphological evaluation of glass vial inner surfaces
by SEM revealed that in general the midbody area for
Figure 2
Representative SEM images of Glass A samples at 10,0003 magnification at different time-points of the wall-
near-bottom area.
190 PDA Journal of Pharmaceutical Science and Technology
on June 14, 2020Downloaded from
both the categories is not affected by corrosion, and it
is smooth and homogeneous. The main degraded area
is the wall-near-bottom one, in agreement with DIC
microscopy inspection.
Before filling and stress treatment, the inner surface of
Glass A vials showed sporadic bulges and shallow
craters on the shoulder and wall-near-bottom areas.
After contact with the placebo solution, these inhomo-
geneities became micropits. The size of the pits did
not really increase through the different time-points,
but rather the microroughness increased, as it is well
visible on the SEM images at higher magnification
(Figure 4).
Figure 3
Representative SEM images of Glass B samples at 10,0003 magnification at different time-points of the wall-
near-bottom area.
Vol. 74, No. 2, March--April 2020 191
on June 14, 2020Downloaded from
Furthermore, it should be noted that the shoulder area,
not directly in contact with the filling solution, showed
micropitting corrosion as well.
An increase of corrosion was observed in the vicinity of
the filling volume line, more pronounced for Glass B
vials (Figure 4). The low filling volume has an influence
on the results owing to the different wetted wall areas,
which are typically not homogeneous but more affected
in case of autoclaving, less in real-time storage.
Hydrolytic Resistance Results
The hydrolytic resistance of the samples was meas-
ured according to the current ISO 4802-1 Hydrolytic
resistance of the interior surfaces of glass containers
(28). Titration values, expressed in milliliters of
0.01 N HCl, for samples of Glass A are higher (mean
value = 0.79) than samples of Glass B (mean value =
0.56).
ICP-OES Results
The results of the extraction study for each time-point
are reported in Table III and Figure 5.
Thirty vials per sample time-point were treated.
Because of the low filling volume (0.7mL), three sam-
ples were pooled together to obtain a total of 10 sam-
ples per each time-point.
Figure 4
Further selected SEM images with different magnifications [(a) 50003, (b) 10,0003, (c) 25,0003, (d) 25,0003,
(e) 10,0003, (f) 25,0003] of Glass A and Glass B samples.
192 PDA Journal of Pharmaceutical Science and Technology
on June 14, 2020Downloaded from
It can clearly be seen that Glass A shows a lower con-
centration of Al, B, and Si than Glass B, except for Al
and Ca in AC treatment that show slightly higher con-
centrations in Glass A.
Throughout the 5 and 12mo of real-time storage,
Glass A reveals the lowest amount of total extract-
ables (maximum about 5 mg/L) at RT5. Glass B
exhibits the highest amount (around 45mg/L) at
AT36.
Figure 5 highlights differences between the two extrac-
tion methods. Real-time aging shows a lower amount
of extractables compared with accelerated aging. After
12mo of storage with accelerated conditions, the num-
ber of elements measured in the solution is higher com-
pared with 12mo at real-time aging (the content of
SiO2 extracted is three times higher).
By a comparison between AC and AT24, Glass A
shows more aluminum and silicon extracted from the
TABLE III
ICP-OES Summarized Resultsa
T0 AC RT5 RT12 RT24 AT12 AT24 AT36
Al2O3 Glass A Average <LoQ 1.14 <LoQ <LoQ 0.08 0.26 0.26 0.30
SD NA 0.10 NA NA 0.01 0.04 0.06 0.07
Glass B Average <LoQ 0.98 <LoQ <LoQ 0.05 0.40 0.35 0.38
SD NA 0.32 NA NA 0.01 0.10 0.09 0.13
B2O3 Glass A Average <LoQ 4.11 1.29 1.63 2.28 4.44 6.24 7.06
SD NA 0.25 0.12 0.21 0.27 0.30 0.48 0.68
Glass B Average <LoQ 8.55 2.97 4.22 5.62 9.55 13.23 13.83
SD NA 0.73 0.91 1.07 1.50 3.34 4.70 4.33
SiO2 Glass A Average <LoQ 21.85 3.43 4.15 7.15 14.03 18.37 20.73
SD NA 1.08 0.24 0.40 0.61 1.33 1.20 2.01
Glass B Average <LoQ 24.28 5.78 7.29 10.82 22.18 28.28 30.18
SD NA 2.81 1.73 1.86 2.70 7.86 10.70 9.57
CaO Glass A Average 0.43 1.24 0.30 0.41 0.54 1.09 1.21 1.37
SD 0.17 0.13 0.02 0.04 0.04 0.09 0.07 0.14
Glass B Average 0.43 0.77 0.25 0.34 0.46 0.81 0.99 1.05
SD 0.15 0.05 0.05 0.07 0.11 0.20 0.25 0.24aThe concentration of the oxides is reported in mg/L. LoQ Al, B, Ca = 0.05; LoQ Si = 0.2. NA, not applicable; RT, real
time; AT, accelerated time; AC, autoclave cycle.
Figure 5
Histograms of the main extracted glass oxides (mg/L) for glasses A and B at different time-points.
Vol. 74, No. 2, March--April 2020 193
on June 14, 2020Downloaded from
AC stress treatment; instead, Glass B shows only more
aluminum extracted from the AC stress treatment.
The results after AC stress treatment are similar for both
the categories, except for extracted boron, which is
higher on Glass B, as reported in Figure 5. The effects
of this treatment on the investigated samples seem to be
independent from their chemical composition.
The different extraction process between stability and
AC is because of the intrinsic features of the glasses
but even owing to the thickness of the dissolved layer,
more marked for AC treatment (11, 29).
The rate of extraction of silica at any time is strongly
related to the concentration of the extracted boron in
both the glasses, as shown in Figure 6 (linear correla-
tion has r2 = 0.9945 and 0.9918 for Glass A and B,
respectively). Thus, the amount of glass elements
brought into solution during the corrosion process
increases linearly with time (29, 30). The SiO2/B2O3
ratio is constant along time and higher for Glass A.
Moreover, Glass B data show a higher dispersion than
Glass A.
Even though real time correlates with the accelerated
time-points, it seems that the rate of extraction
between real time and accelerated has a different
behavior. Throughout 5, 12, and 24mo of real-time
storage, the silicon and boron gradient of extraction is
lower than 12, 24, and 36mo of accelerated time
storage.
AC stress treatment values of both A and B glasses
show a different behavior that does not match the linear
trend of stability time-points (data not shown).
The following mathematical model, as a discrete func-
tion, seems to better represent the behavior of the dif-
ferent types of glass here considered:
Xi¼ n
i¼ 0
½SiO2�i ¼ ktn (1)
where n represents the nth measurement at time tn.
“Cumulative silica” is the first member of eq 1: It rep-
resents the sum of all the silica concentrations meas-
ured at the different ti time values from i = 0 to i = n.
This model is particularly useful because the experi-
mental data fit perfectly with the linear eq 1 (Figure 7)
and, hence, the k value can well represent the efficiency
of the silica release.
It is worth noting that the slope of the line for Glass B
is higher than that of Glass A, even though their initial
values at T0 are equal. It could indicate that Glass B
samples are affected by a more aggressive corrosion
process because they are less chemically resistant than
the ones of Glass A. A similar difference can be
Figure 6
Plot of SiO2 vs B2O3 extracted at different time-
points (real and accelerated time).
Figure 7
Plot of cumulative SiO2 (mg/L) vs different time-
points (mo) at two different stability conditions. In
blue, the average data from Glass B (filled square =
accelerated/simulated time; empty square = real-
time). In red, the average data from Glass A (filled
circle = accelerated/simulated time; empty circle =
real-time).
194 PDA Journal of Pharmaceutical Science and Technology
on June 14, 2020Downloaded from
observed within real-time data; it should be noted that
real-time stability seems to be less aggressive than the
accelerated one for the investigated samples.
Glass corrosion should be related to the chemical com-
position: Glass A has a higher content of SiO2, not al-
kali-mixed (only NaO2) and more CaO than Glass B.
The presence of K2O can decrease the superficial phys-
icochemical stability of the glass (30) and thus weaken
the glass when the leaching (ion-exchange) process
has already occurred. It should be noted that the
different species of alkaline ions show different
behaviors with respect to the leaching phenomenon,
depending on temperature and radius of the cations
(4): In borosilicate glasses, alkaline elements occupy
the interstitial sites closing the silica matrix. K+ ion
has a larger ionic radius with a consequent weaker
attractive force exerted on it by the oxygen, compared
with Na+ (31, 32).
Conclusions
Glass vials manufactured using two glass tubes having
different chemical compositions were studied and com-
pared in terms of their resistance to corrosion after fill-
ing with a nonbuffered ionic strength solution (0.3%
NaCl).
To get more insight on the relation between the glass
composition and corrosion phenomenon and to try to
mitigate the effect of all the factors that generally influ-
ence glass degradation, the vials were manufactured
according to Ompi LDP process.
To give prominence to the importance of selecting the
most suitable raw material at the early stage of glass
container design, two different glass suppliers (A and
B) were selected.
Aging and stability testing approaches were compared
in terms of hydrolytic and corrosion resistance for a
glass in contact with an ionic strength solution. The
morphological assessment of corrosion was studied
through DIC and SEM microscopy-based techniques.
Glass B showed a better hydrolytic resistance than
Glass A by EP titration values and by the morphology
of the inner surface of the vials before filling, where
more inhomogeneities, that are bulges of borates, were
observed on the surface of Glass A. The hydrolytic re-
sistance of Glass B could be related to its chemical
composition, in particular to the higher content of alu-
mina and mixed of alkali (Na2O and K2O).
The scenario is different when an ionic strength solution
is used, in a slow reaction with a high SA/V ratio. Glass
B samples showed a more corroded inner surface, in
terms of microroughness, than Glass A samples. Also,
ICP-OES results of Glass A samples showed lower con-
tents of Al, B, and Si extracted than samples of Glass B
in all the different storage/stress conditions. Based on
the cumulative extracted SiO2, the corrosion process
seems the same for both the glasses, but Glass B shows
a lower chemical resistance than Glass A.
It is well-known that increasing SA/V ratios efficiently
provide accelerated glass surface reactions in the rele-
vant vial lower area, but the use of elevated tempera-
ture, as when applying the AC stress treatment, does
not always and univocally simulate the real-time
effects (29).
In the present study, samples were submitted to an AC
cycle of 1 h at 121 ˚C, and the analytical results did not
show representative differences in terms of glass corro-
sion between the categories (Glass A and Glass B).
Acceleration of glass by a high-temperature AC system
does not accurately represents the surface changes
occurring during low-temperature glass exposure.
Real-time and accelerated stability testing showed non-
negligible differences between their respective effects.
The accelerated aging results in a worst-case scenario
compared with the real-time stress test, and the auto-
claving procedure is the topmost stress program.
This scenario shows that the chemical durability of a
glass is dependent on the chemical composition and the
kinetic and thermodynamic features of the entire sys-
tem (4). Real-time stability testing provides the most
reliable data to test the integrity of the package mate-
rial and the integrity at the interface between glass and
a drug product.
Durability tests that are usually performed, for example
to extend the shelf life of a product or service condi-
tions, should consider detailed information about the
glass chemical composition and the variation of glass
local structure with composition and preparation condi-
tions, to predict corrosion behavior.
Comparing different behaviors of the raw materials in
terms of glass durability can help in the important
Vol. 74, No. 2, March--April 2020 195
on June 14, 2020Downloaded from
selection phase of the most suitable glass container
before production.
Nevertheless, further analysis is rather needed to
understand in depth the relationship between chemical
durability and corrosion, and all the other factors that
could somehow damage the chemical surface of the
pharmaceutical glass.
Acknowledgments
The authors would like to thank Emanuel Guadagnino
and Maria Chiara Frare for constructive discussion in the
preparation of the manuscript, as well as Nicolo
Mazzucco and Nicola Bessegato for the analytical and
technical support during SEM and ICP-OES analyses.
References
1. Schaut, R. A.; Weeks, P. W. Historical Review of
Glasses Used for Parenteral Packaging. PDA J.
Pharm. Sci. Technol. 2017, 71 (4), 279–296.
2. Dimbleby, V. Glass for Pharmaceutical Purposes.
J. Pharm. Pharmacol. 1953, 5 (1), 969–989.
3. Douglas, R. W.; El-Shamy, T. M. M. Reactions of
Glasses with Aqueous Solutions. J. Am. Ceram.
Soc. 1967, 50 (1), 1–8.
4. Paul, A. Chemical Durability of Glasses; a Thermo-
dynamic Approach. J. Mater. Sci. 1977, 12 (11),
2246–2268.
5. Bunker, B. C. Molecular Mechanisms for Corro-
sion of Silica and Silicate Glasses. J. Non-Cryst.
Solids 1994, 179, 300–308.
6. Boltres, B.; Tratzky, S.; Kass, C.; Eichholz, R.; Nass,
P. There Is Still Room for Improvement: Presentation
of a Neutral Borosilicate Glass with Improved Chem-
ical Stability for Parenteral Packaging. PDA J.
Pharm. Sci. Technol. 2016, 70 (4), 346–352.
7. Franz, H. Durability and Corrosion of Silicate Glass
Surfaces. J. Non-Cryst. Solids 1980, 42 (1–3),
529–534.
8. Hellmann, R.; Cotte, S.; Cadel, E.; Malladi, S.;
Karlsson, L. S.; Lozano-Perez, S.; Cabie, M.;
Seyeux, A. Nanometre-Scale Evidence for Interfacial
Dissolution-Reprecipitation Control of Silicate Glass
Corrosion. Nature Mater. 2015, 14 (3), 307–311.
9. Araujo, R. Influence of Boron-Oxygen Bonding
on Glass Properties. J. Non-Cryst. Solids 1997,
222, 25–32.
10. Das, C. R. Diffusion-Controlled Attack of Glass
Surfaces by Aqueous Solutions. J. Am. Ceram. Soc.
1980, 63 (3–4), 160–165.
11. Guadagnino, E.; Verita, M.; Furlani, C.; Polzonetti,
G. Aluminium Release of Pharmaceutical Glass
Containers: Determination by GFAAS in the Extract
Solutions and Study of the Inner Surfaces by XPS
and SIMS. Glastech. Ber. 1990, 64 (7), 179–184.
12. Newton, R. G. The Durability of Glass—A
Review. Glass Technol. 1985, 26, 1:21–38.
13. Iacocca, R. G.; Allgeier, M. Corrosive Attack of
Glass by a Pharmaceutical Compound. J. Mater.
Sci. 2007, 42 (3), 801–811.
14. Iacocca, R. G.; Tolt, N.; Allgeier, M.; Bustard, B.;
Dong, X.; Foubert, M.; Hofer, J.; Peoples, S.; Shel-
bourn, T. Factors Affecting the Chemical Durabil-
ity of Glass Used in the Pharmaceutical Industry.
AAPS Pharm. Sci. Tech. 2010, 11 (3), 1340–1349.
15. White, W. B. Theory of Corrosion of Glass and
Ceramics. In Corrosion of Glass, Ceramics and
Superconductors; Clarke, D. E.; Zoitos, B. K., Eds.;
Noyes Publications: Park Ridge, 1992; 2, pp 2–28.
16. Ditter, D.; Mahler, H. C.; Roehl, H.; Wahl, M.; Huwy-
ler, J.; Nieto, A.; Allmendinger, A. Characterization
of Surface Properties of Glass Vials Used as Pri-
mary Packaging Material for Parenterals. Eur. J.
Pharm. Biopharm. 2018, 125, 58–67.
17. Ditter, D.; Nieto, A.; Mahler, H. C.; Roehl, H.;
Wahl, M.; Huwyler, J.; Allmendinger, A. Evalua-
tion of Glass Delamination Risk in Pharmaceutical
10 mL/10R Vials. J. Pharm. Sci. 2018, 107 (2),
624–637.
18. Sloey, C.; Gleason, C.; Phillips, J. Determining
the Delamination Propensity of Pharmaceutical
Glass Vials Using a Direct Stress Method. PDA J.
Pharm. Sci. Technol. 2013, 67 (1), 35–42.
196 PDA Journal of Pharmaceutical Science and Technology
on June 14, 2020Downloaded from
19. Rothaar, U.; Klause, M.; Hladik, B. Comparative
Delamination Study to Demonstrate the Impact
of Container Quality and Nature of Buffer Sys-
tem. PDA J. Pharm. Sci. Technol. 2016, 70 (6),
560–567.
20. Borchert, S. J.; Ryan, M. M.; Davison, R. L.;
Speed, W. Accelerated Extractable Studies of Bor-
osilicate Glass Containers. J. Parenter. Sci. Tech-
nol. 1989, 43 (2), 67–79.
21. Waterman, K. C.; Adami, R. Accelerated Aging:
Prediction of Chemical Stability of Pharmaceuti-
cals. Int. J. Pharmaceut. 2005, 293 (1–2), 101–125.
22. Wen, Z.; Torraca, G.; Masatani, P.; Sloey, C.; Phil-
lips, J. Nondestructive Detection of Glass Vial
Inner Surface Morphology with Differential Inter-
ference Contrast Microscopy. J. Pharm. Sci. 2012,
101 (4), 1378–1384.
23. Lyle, A. K. Theoretical Aspects of Chemical Attack
of Glasses by Water. J. Am. Ceram. Soc. 1943,
26 (6), 201–204.
24. Bacon, F. R. Chemical Durability of Silicate Glass.
Glass Industry 1968, 49, 438–446.
25. Newton, R. G.; Davison, S. Conservation of Glass,
Butterworths: London, 1989.
26. Hench, L. L. Characterization of Glass Corrosion
and Durability. J. Non-Cryst. Solids 1975, 19, 27–39.
27. Schwarzenbach, M. S.; Reimann, P.; Thommen,
V.; Hegner, M.; Mumenthaler, M.; Schwob, J.;
G€untherodt, H.-J. Topological Structure and
Chemical Composition of Inner Surfaces of Boro-
silicate Vials. PDA J. Pharm. Sci. Technol. 2004,
58 (3), 169–175.
28. International Organization for Standardization, ISO
4802-1:2016 (E) Glassware-Hydrolytic Resistance
of the Interior Surfaces of Glass Containers. ISO:
Geneva, 2016.
29. Hench, L. L.; Clark, D. E. Physical Chemistry of
Glass Surfaces. J. Non-Cryst. Solids 1978, 28 (1),
83–105.
30. Guadagnino, E.; Zuccato, D. Delamination Propen-
sity of Pharmaceutical Glass Containers by Acceler-
ated Testing with Different Extraction Media. PDA
J. Pharm. Sci. Technol. 2012, 66 (2), 116–125.
31. Scholze, H. Glass Nature, Structure and Proper-
ties, Springer Verlag: New York, 1991.
32. Verita, M. Le vetrate artistiche: Struttura, composi-
zione, proprieta chimico-fisiche dei Vetri. In Lesverres
et l’etatvitreux; Zarzycki, J., Ed.; Masson: Paris, 1982.
Vol. 74, No. 2, March--April 2020 197
on June 14, 2020Downloaded from
Appendix: Supplementary Material
Figure S1
Representative DIC-OM images of the wall-near-bottom area, Glass A samples at 1003 magnification at differ-
ent time-points.
Figure S2
Representative DIC-OM images of the wall-near-bottom area, Glass B samples at 1003 magnification at differ-
ent time-points.
198 PDA Journal of Pharmaceutical Science and Technology
on June 14, 2020Downloaded from
Figure S3
SEM images of Glass A samples at the wall-near-bottom area (10,0003 magnification).
Vol. 74, No. 2, March--April 2020 199
on June 14, 2020Downloaded from
Figure S4
SEM images of Glass B samples at the wall-near-bottom area (10,0003 magnification).
200 PDA Journal of Pharmaceutical Science and Technology
on June 14, 2020Downloaded from
Authorized User or for the use by or distribution to other Authorized Users·Make a reasonable number of photocopies of a printed article for the individual use of an·Print individual articles from the PDA Journal for the individual use of an Authorized User ·Assemble and distribute links that point to the PDA Journal·Download a single article for the individual use of an Authorized User·Search and view the content of the PDA Journal permitted to do the following:Technology (the PDA Journal) is a PDA Member in good standing. Authorized Users are An Authorized User of the electronic PDA Journal of Pharmaceutical Science and
copyright information or notice contained in the PDA Journal·Delete or remove in any form or format, including on a printed article or photocopy, anytext or graphics·Make any edits or derivative works with respect to any portion of the PDA Journal including any·Alter, modify, repackage or adapt any portion of the PDA Journaldistribution of materials in any form, or any substantially similar commercial purpose·Use or copy the PDA Journal for document delivery, fee-for-service use, or bulk reproduction orJournal or its content·Sell, re-sell, rent, lease, license, sublicense, assign or otherwise transfer the use of the PDAof the PDA Journal ·Use robots or intelligent agents to access, search and/or systematically download any portion·Create a searchable archive of any portion of the PDA JournalJournal·Transmit electronically, via e-mail or any other file transfer protocols, any portion of the PDAor in any form of online publications·Post articles from the PDA Journal on Web sites, either available on the Internet or an Intranet,than an Authorized User· Display or otherwise make any information from the PDA Journal available to anyone otherPDA Journal·Except as mentioned above, allow anyone other than an Authorized User to use or access the Authorized Users are not permitted to do the following:
on June 14, 2020Downloaded from